Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Researchers sought to determine whether combination decitabine, venetoclax, and ponatinib would be effective in patients with accelerated phase CML.

Researchers identified risk factors for postoperative nausea and vomiting in patients with lung cancer who underwent thoracoscopic surgery.

Higher Healthy Eating Index score linked to significantly lower risk for grade reclassification in men undergoing active surveillance.

Researchers sought to determine whether a low dose of bosutinib followed by escalation would be effective for patients with CML.

Patients with early breast cancer who are at risk of late relapse after breast-conserving surgery may derive little benefit from adjuvant radiotherapy, research suggests.

Researchers investigated whether naldemedine could help prevent opioid-induced constipation among patients with cancer.

In a review of studies, researchers identified the need for malnutrition screening and recommended 6 validated tools for nutritional assessment in the outpatient setting.

Researchers sought to determine the genomic aberrations that may be linked with relapse in pediatric patients with B-ALL.

Decitabine plus venetoclax and ponatinib appeared safe and elicited responses in a phase 2 trial of patients with advanced phase CML.

A review of data demonstrated that female patients with MM experience worse adverse effects, PFS, and OS with higher treosulfan doses, compared with male patients.

For individuals with obesity, metabolic-bariatric surgery (MBS) is associated with a reduced risk for pancreatic cancer, ...